HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Eyes Industry-Proposed Lead Limit, With Lipstick Report Slated For Fall

This article was originally published in The Rose Sheet

Executive Summary

FDA is expected to release a report detailing its findings on lead in lipstick this fall, but it remains to be seen whether the agency will heed industry requests to set a maximum limit for the trace contaminant in cosmetic products.

Related Content

EWG: FDA Should Raise Bar On Lead In Cosmetics; Innovation Will Follow
FDA’s Holiday Gift To Cosmetics Industry: 10ppm Recommended Lead Cap
EWG Lawsuit Slams FDA’s Failure To Act On ‘Formaldehyde-Laced’ Hair Smoothers
Rep. Meng Urges FDA To Ban Harmful Colorants From Feminine Washes
FDA Will Respond To Lipstick Lead-Limit Petition In March
FDA Studies Trace Element Content In Cosmetics; Guidance To Come?
ICCR Accepts Four Regulatory Guidance Reports; NGOs Seek Bigger Role
FDA’s Lead-In-Lipstick Testing Completed, Cosmetics Director Says
FDA’s Lead-In-Lipstick Testing Completed, Cosmetics Director Says
Senators Request FDA Inquiry Into Lead Discovered In Lipstick Products



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts